Arvinas, Inc. (ARVN) vs Phathom Pharmaceuticals, Inc. (PHAT)

• Arvinas, Inc. ARVN 7.56 ▼ −3.82%
• Phathom Pharmaceuticals, Inc. PHAT 5.80 ▲ +1.05%

Arvinas, Inc. and Phathom Pharmaceuticals, Inc. are both Biotechnology companies. Arvinas, Inc. is the larger, with a market value of $513.9M against $466.6M — 1.1× the size. Phathom Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 41.0×. Phathom Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 110.2% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs −41.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Arvinas, Inc. leads on 9 and Phathom Pharmaceuticals, Inc. on 6.